Diagnostics firm Bio-Rad in talks to merge with Qiagen – WSJ
California-based diagnostics company Bio-Rad Laboratories is in talks to merge with Qiagen NV , the Wall Street Journal reported on Monday, citing people familiar with the matter.
Talks between the two companies have been going on for a while but an agreement unlikely for another few weeks, the report said.
Bio Rad, which manufactures and supplies products such as laboratory apparatus, instruments and diagnostics, has a market cap of $12.85 billion.
Both Qiagen and Bio-Rad did not immediately respond to Reuters’ requests for comments. (Reporting by Bhanvi Satija in Bengaluru; Editing by Vinay Dwivedi)
Comments are closed.